Euglycemic Diabetic Ketoacidosis in a Pregnant Patient on Insulin Pump Therapy by Hesham Yasin, MD, Jordan D. Ross, MD, James Turner, MD, Samuel Dagogo-Jack, MD, DSc

Subjects: Get full text

Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus by Joanna Tołwińska, Barbara Głowińska-Olszewska, Artur Bossowski

Get full text

The Impact of a Pure Protein Load on the Glucose Levels in Type 1 Diabetes Patients Treated with Insulin Pumps by Tomasz Klupa, Teresa Benbenek-Klupa, Bartlomiej Matejko, Sandra Mrozinska, Maciej T. Malecki

“…We aimed to estimate the impact of ingestion of a pure protein load on the glucose levels in T1DM patients treated with insulin pumps. We examined 10 T1DM patients (6 females, mean age—32.3 years, mean HbA1c—6.8%) treated with insulin pumps equipped with a continuous glucose monitoring system (CGMS). …”
Get full text

Pilot Study of a Modified DOPS Scale for Insulin Pump and CGM Installation Training in Chinese Medical Students During Endocrinology Rotations by Yuan Y, Wang C, Wen S, Li Y, Xu C, Yu F, Li X, He Y, Chen L, Ren Y, Zhou L

Subjects: Get full text

Performance of a Continuous Subcutaneous Insulin Infusion (CSII) Pump With Acoustic Volume and Flow Sensing in Simulated High-Consequence Situations by Robert D. Butterfield, Nathaniel M. Sims

Subjects: Get full text

Trends in Glycemia between 2002 and 2016 among Incident Youth Cohorts Early in the Course of Type 1 Diabetes: The SEARCH for Diabetes in Youth Study by Daria Igudesman, Beth A. Reboussin, Katherine J. Souris, Catherine Pihoker, Lawrence Dolan, Jean M. Lawrence, Sharon Saydah, Dana Dabelea, Santica Marcovina, Noémie Clouet-Foraison, Faisal S. Malik, Elizabeth J. Mayer-Davis

“…We tested the hypothesis that there were temporal trends in population-level glycemia and insulin pump use near T1D diagnosis among incident youth cohorts diagnosed between 2002 and 2016. …”
Get full text

Effect of Optimization of Glycaemic Control on Mannan-Binding Lectin in Type 1 Diabetes by Gry Høst Dørflinger, Charlotte Brink Holt, Steffen Thiel, Jakob Appel Østergaard, Troels Krarup Hansen

“…We measured MBL, fructosamine, and HbA1cat baseline and after 6 weeks in 52 type 1 diabetic patients following the change from conventional insulin therapy to insulin pump therapy. Results. After initiation of insulin pump therapy, the total daily insulin dose was significantly reduced (from 51 ± 18 IE/day to 39 ± 13 IE/day, P<0.0001). …”
Get full text

Acute Hyperglycemia Due to Topical Corticosteroid Administration by Laura Y. Sue, Anna Milanesi

“…His insulin requirements, via his insulin pump, increased to nearly five times his typical daily dose. …”
Get full text

Management of Neonatal Diabetes due to a KCNJ11 Mutation with Automated Insulin Delivery System and Remote Patient Monitoring by Ming Yeh Lee, Anna L. Gloyn, David M. Maahs, Priya Prahalad

“…We describe the use of continuous glucose monitoring (CGM), insulin pump, automated insulin delivery system, and remote patient monitoring technologies to facilitate rapid and safe outpatient cross-titration from insulin to oral sulfonylurea. …”
Get full text

Acute Psychosis in Withdrawal from Nicotine Vaping in a Young Man with Comorbid Diabetic Ketoacidosis and Cannabis Use by Kyle J. Rutledge, Dianne L. Plath

“…The current report presents the case of a young man with multiple medical comorbidities, including insulin-dependent diabetes mellitus on an insulin pump and presumed Gilbert’s disease, and chronic cannabis use who experienced acute agitation with hallucinations in the context of quitting his vape pen “cold turkey” or abruptly discontinuing use without a nicotine replacement. …”
Get full text

A Survey of Insulin-Dependent Diabetes—Part I: Therapies and Devices by Daisuke Takahashi, Yang Xiao, Fei Hu, Michael Lewis

“…These medical devices include automated insulin pumps and blood glucose sensors. Insulin pumps are designed to create artificial insulin perfusion while they largely rely on the blood glucose profile measurements and these measurements are achieved by one or more blood glucose sensors. …”
Get full text

Drug resistant epilepsy as the consequence of inadequate control of type 1 diabetes by Ewa M. Sokolewicz, Kamil Dzwilewski, Natalia Omieczyńska, Marta Zawadzka, Maria Mazurkiewicz-Bełdzińska

“…Here, we report a case of an 11-year old male patient diagnosed with type 1 diabetes mellitus treated with the use of insulin pump who was admitted to the Pediatric Neurology Department because of multiple incidents of seizures. …”
Get full text

Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey by Jingwen Liu, Jeoffrey Bispham, Ludi Fan, Jiat-Ling Poon, Allyson Hughes, Alicia Mcauliffe-Fogarty, Oralee Varnado, Beth Mitchell

“…Multivariable regressions were performed on assessment scores.Results The study included 494 participants (mean±SD age 43.9±12.2 years, duration of T1D mellitus 16.6±16.8 years, self-reported glycosylated hemoglobin (HbA1c) 6.9%±0.8% (52±9 mmol/mol)), 63% men, 89% on insulin pump, 25% experienced a severe hypoglycaemic event in the last 6 months. …”
Get full text

Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus... by Toshiki Kogai, Junko Sato, Haruna Yasuda, Tatsuhiro Ayame, Azusa Ozaki, Eri Takagi, Mami Koshibu, Yuya Nishida, Fuki Ikeda, Hirotaka Watada

“…ABSTRACT Aims/Introduction We evaluated the effect of the MiniMed™ 770G, an insulin pump using hybrid closed‐loop technology, on blood glucose management and quality of life in Japanese people with type 1 diabetes. …”
Get full text

Application of multidisciplinary team management by using the PDCA approach in blood glucose control of elderly patients with type 2 diabetes (多学科PDCA血糖管理模式在老年2型糖尿病患者中的应用)... by FAN Meihong (樊美红), LI Yuxia (李玉霞)

“…All patients received routine nursing, insulin-pump therapy and Flash Glucose Monitoring, and those in the observation group were given multidisciplinary team management by using the PDCA approach. …”
Get full text

Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a randomized... by Anthony C Keech, Vijaya Sundararajan, Bruce R King, Sara Vogrin, Richard J MacIsaac, Leon A Bach, Jane Speight, Alicia J Jenkins, Christel Hendrieckx, David O’Neal, Sybil A McAuley, Geoff R Ambler, Fergus J Cameron, Jan M Fairchild, Elizabeth A Davis, Timothy W Jones, Morton G Burt, Philip M Clarke, Neale D Cohen, Peter G Colman, Joey Kaye, Kavita Kumareswaran, Melissa H Lee, Roland W Mccallum, Barbora Paldus, Stephen N Stranks, Steven Trawley, Glenn M Ward, David N O’Neal, Sienna Russell-Green, Deborah Jane Holmes-Walker, Benjamin Lam, Jennifer A Halliday, Glenn Ward, Catriona M Sims, D Jane Holmes-Walker, Andrzej Januszewski, Hanafi Mohammed Husin, Martin I de Bock, Mary B Abraham

“…Introduction This analysis aimed to investigate diabetes-specific psychological outcomes among adults with type 1 diabetes (T1D) using hybrid closed-loop (HCL) versus standard therapy.Research design and methods In this multicenter, open-label, randomized, controlled, parallel-group clinical trial, adults with T1D were allocated to 26 weeks of HCL (MiniMed™ 670G) or standard therapy (insulin pump or multiple daily injections without real-time continuous glucose monitoring). …”
Get full text

Enhanced Cognitive Walkthrough: Development of the Cognitive Walkthrough Method to Better Predict, Identify, and Present Usability Problems by Lars-Ola Bligård, Anna-Lisa Osvalder

“…The ECW method has been employed to evaluate user interface designs of medical equipment such as home-care ventilators, infusion pumps, dialysis machines, and insulin pumps. The method has proved capable of identifying several potential use problems in designs.…”
Get full text

Travel with Diabetes: A Comprehensive Review for Clinicians by Venkatraman Rajkumar

“…This article discusses blood glucose monitoring, air travel security, precautions with continuous glucose monitors and insulin pumps during ascent and descent of aircraft, insulin dosage adjustments during travel beyond time zones, proper preservation of insulin in extreme temperatures, and adaptation to high altitude, hot and cold environments for patients with diabetes. …”
Get full text

Diabetes Technology: Markers, Monitoring, Assessment, and Control of Blood Glucose Fluctuations in Diabetes by Boris P. Kovatchev

“…Technology integrating CGM with insulin pumps is now available, opening the field for automated closed-loop control, known as the artificial pancreas. …”
Get full text

Use and Trends of Diabetes Self-Management Technologies: A Correlation-Based Study by Jesús Fontecha, Iván González, Alfonso Barragán, Theodore Lim

“…In this study, more than 70% of participants use Continuous Glucose Systems and additional devices (41.85% also use insulin pumps) which impacts positively on the knowledge of incoming technologies. …”
Get full text